文献速递围术期管理与 ERAS

改良Hasson法建立后腹腔的对比研究

[A comparative study of the retroperitoneal cavity established by the modified Hasson in urology].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2021-01-01

回顾性分析83例后腹腔镜手术患者,比较Hasson法与改良Hasson法建立后腹腔的安全性和并发症。改良Hasson组切皮至建腔时间更短、建腔出血量更少,套管切口疝和皮下气肿发生率更低,作者认为该法简单快速安全。

要点

  • 改良Hasson组切皮至建腔时间(5.32±1.36)min短于Hasson组(8.56±2.64)min。
  • 改良Hasson组建腔出血量(9.85±3.55)ml少于Hasson组(15.32±6.09)ml。
  • 改良Hasson组套管切口疝和皮下气肿发生率均低于Hasson组。

核心结论

  • 作者认为改良Hasson法建立后腹腔安全、简单、快速、可行,为泌尿外科医师提供了一种有效且便于实施、并发症更少的选择。

研究设计与样本

  • 回顾性分析山西白求恩医院泌尿外科2020年1月至2021年6月收治的83例接受后腹腔镜手术患者的病例资料,男性47例、女性36例,年龄(48.3±11.3)岁(范围35~71岁)。
  • Hasson组43例,第1通道选择在第12肋与腋后线交界处或腰三角处;改良Hasson组40例,第1通道选择在腋中线上髂嵴上1.5 cm处。
  • 采用t检验、χ²检验、Fisher确切概率法比较两组手术安全性指标及并发症。

主要发现

  • 两组性别、年龄、体重指数、腰长、身高差异均无统计学意义(P>0.05)。
  • 改良Hasson组切皮至建立后腹腔时间(5.32±1.36)min短于Hasson组(8.56±2.64)min,t=6.949,P<0.01。
  • 改良Hasson组建腔出血量(9.85±3.55)ml少于Hasson组(15.32±6.09)ml,t=4.951,P<0.01。
  • 改良Hasson组套管切口疝发生率2.5%(1/40)低于Hasson组20.9%(9/43),P=0.015。
  • 改良Hasson组皮下气肿发生率2.5%(1/40)低于Hasson组18.6%(8/43),P=0.030。

关键数值与推荐

  • Hasson组第1通道选择在第12肋与腋后线交界处或腰三角处。
  • 改良Hasson组第1通道选择在腋中线上髂嵴上1.5 cm处。

临床怎么用

  • 作者认为改良Hasson法建立后腹腔安全、简单、快速、可行,为泌尿外科医师提供了一种有效且便于实施、并发症更少的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To examine the safety and complications of two methods of establishing retroperitoneal cavity in urology. Methods: Totally 83 patients undergoing retroperitoneal laparoscopic surgery in Department of Urology, Shanxi Bethune Hospital from January 2020 to June 2021 were analyzed retrospectively. There were 47 males and 36 females, aged (48.3±11.3) years (range: 35 to 71 years). Forty-three cases in Hasson group(the first Trocar channel was selected at the junction of the 12th rib and the posterior axillary line or lumbar triangle), 40 cases in modified Hasson group(the first Trocar channel is selected at 1.5 cm above the iliac crest on the mid-axillary line). The t test, χ² test, and Fisher exact test were used to compare the surgical safety indicators and complications of the two groups of patients. Results: There was no statistical difference between the two groups in gender, age, body mass index, waist length, and height (P>0.05). The comparison of safety indicators, included the time from skin incision to establishment of the retroperitoneal cavity and the amount of bleeding from the cavity were statistical difference between the two groups (P<0.05). Compared to that in Hasson group, the time from skin incision to establishment of the abdominal cavity in modified Hasson group was shorter ((8.56±2.64) minutes vs. (5.32±1.36) minutes, t=6.949, P<0.01), the blood loss of establishment was less ((15.32±6.09) ml vs. (9.85±3.55) ml, t=4.951, P<0.01). In terms of complication indicators, the incidence of Trocar hernia and the number of subcutaneous emphysema in modified Hasson group were lower than that in Hasson group (20.9% (9/43) vs. 2.5% (1/40), P=0.015, 18.6% (8/43) vs. 2.5% (1/40), P=0.030). Conclusions: The modified Hasson group is a safe method of establishing retroperitoneal cavity. The technique is simple and fast. It provides urologists with a more effective and easy-to-implement option with fewer complications. 目的: 探讨泌尿外科后腹腔镜手术中两种建立后腹腔方法的安全性和并发症。 方法: 回顾性分析山西白求恩医院泌尿外科2020年1月至2021年6月收治的83例接受后腹腔镜手术患者的病例资料。男性47例,女性36例,年龄(48.3±11.3)岁(范围:35~71岁)。43例采用Hasson方法建立后腹腔(Hasson组,第1通道选择在第12肋与腋后线交界处或腰三角处),40例采用改良Hasson方法建立后腹腔(改良Hasson组,第1通道选择在腋中线上髂嵴上1.5 cm处)。采用t检验、χ²检验、Fisher确切概率法比较两组患者手术安全性指标及并发症。 结果: 两组患者的性别、年龄、体重指数、腰长、身高差异均无统计学意义(P>0.05)。与Hasson组相比,改良Hasson组从切皮到建立后腹腔时间更短[(8.56±2.64)min比(5.32±1.36)min,t=6.949,P<0.01],建腔出血量更少[(15.32±6.09)ml比(9.85±3.55)ml,t=4.951,P<0.01]。改良Hasson组的套管切口疝、皮下气肿发生率低于Hasson组[20.9%(9/43)比2.5%(1/40),P=0.015;18.6%(8/43)比2.5%(1/40),P=0.030]。 结论: 改良Hasson法建立后腹腔,技术简单、快速、可行,为泌尿外科医师提供了一种有效和便利的选择。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ren RM, Ma D, Yuan S, et al. [A comparative study of the retroperitoneal cavity established by the modified Hasson in urology]. Zhonghua Wai Ke Za Zhi. 2021. PMID: 34743452. doi:10.3760/cma.j.cn112139-20210706-00293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。